CAD & Atherosclerosis
Conference Coverage
Real-world data support safety of newer LAA device
More than 18 months after approval, the Watchman FLX left atrial appendage closure device is performing well at 45 days in real-world use.
From the Journals
Guidance seeks to improve statin treatment adherence
A systematic review of trials estimated that between up to 78% of statin intolerance could be attributed to expectation alone.
Conference Coverage
Big missed opportunities for BP control in premenopausal women
A new NHANES analysis found no improvement in hypertension control over the past decade and evidence of racial and ethnic disparities in these...
Feature
Cardiologist pleads guilty to abusive sexual contact
The former head of cardiology at the Palo Alto VA Hospital from 1985 to 2018 pleaded guilty to one count of abusive sexual contact of a junior...
From the Journals
CV risk biomarkers tentatively identified in psoriatic disease
Troponin I and NT-proBNP levels were linked to cardiovascular risk independently of the Framingham Risk Score.
From the Journals
Early treatment may delay atherosclerosis in familial hypercholesterolemia
Cholesterol-lowering treatment early in life appeared to slow intima-media growth in a meta-analysis.
From the Journals
How Lp(a) can help improve ASCVD risk assessment
Calcium scores and lipoprotein(a) levels predict 10-year risk independent of each other, and together could swing shared decision-making about...
From the Journals
New data explore risk of magnetic interference with implantable devices
Portable electronics embedded with magnets powerful enough to impair CV device functions are proliferating.
From the Journals
More than half of U.S. women enter pregnancy at higher CVD risk
A minority of women in the United States enter pregnancy in favorable cardiovascular health, new research suggests.
From the Journals
Excess sodium in soluble acetaminophen tied to CVD risk, death
“The weight of the evidence makes ongoing inaction on sodium-containing medications untenable.”
From the Journals
AHA targets ‘low-value’ heart care in new scientific statement
Low-value cardiovascular care providing little or no benefit is common, potentially harmful, and costly, and it will take key stakeholders to...